journal
MENU ▼
Read by QxMD icon Read
search

JAMA Cardiology

journal
https://www.readbyqxmd.com/read/28514481/outside-the-door
#1
C Nicholas Cuneo
No abstract text is available yet for this article.
May 17, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28514465/bicuspid-aortopathy-reply
#2
Victoria Delgado, William K F Kong, Jeroen J Bax
No abstract text is available yet for this article.
May 17, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28514456/correction-of-95-ci-in-table
#3
(no author information available yet)
No abstract text is available yet for this article.
May 17, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28494076/the-balance-between-access-and-quality-in-transcatheter-valve-therapies
#4
Patrick T O'Gara
No abstract text is available yet for this article.
May 11, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28494061/association-between-hospital-volume-and-30-day-readmissions-following-transcatheter-aortic-valve-replacement
#5
Sahil Khera, Dhaval Kolte, Tanush Gupta, Andrew Goldsweig, Poonam Velagapudi, Ankur Kalra, Gilbert H L Tang, Wilbert S Aronow, Gregg C Fonarow, Deepak L Bhatt, Herbert D Aronow, Neal S Kleiman, Michael Reardon, Paul C Gordon, Barry Sharaf, J Dawn Abbott
Importance: With the approval of transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic aortic stenosis at intermediate surgical risk, TAVR volume is projected to increase exponentially in the United States. The 30-day readmission rate for TAVR was recently reported at 17.9%. The association between institutional TAVR volume and the 30-day readmission metric has not been examined. Objective: To assess the association between hospital TAVR volume and 30-day readmission...
May 11, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28494050/determinants-associations-consequences-and-prevention-of-readmissions-after-transcatheter-aortic-valve-replacement
#6
John D Carroll
No abstract text is available yet for this article.
May 11, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492933/myocardial-fibrosis-in-duchenne-and-becker-muscular-dystrophy-reply
#7
Marly Conceição Silva, Clerio Francisco Azevedo, Carlos Eduardo Rochitte
No abstract text is available yet for this article.
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492931/the-controversial-epidemiology-of-left-ventricular-dysfunction-in-patients-with-myotonic-dystrophy-type-1-reply
#8
Tanyanan Tanawuttiwat, Gordon Tomaselli, Saman Nazarian
No abstract text is available yet for this article.
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492916/myocardial-fibrosis-in-duchenne-and-becker-muscular-dystrophy
#9
Robert C Bahler
No abstract text is available yet for this article.
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492915/sildenafil-treatment-in-heart-failure-with-preserved-ejection-fraction-targeted-metabolomic-profiling-in-the-relax-trial
#10
Hanghang Wang, Kevin Anstrom, Olga Ilkayeva, Michael J Muehlbauer, James R Bain, Steven McNulty, Christopher B Newgard, William E Kraus, Adrian Hernandez, G Michael Felker, Margaret Redfield, Svati H Shah
Importance: Phosphodiesterase-5 inhibition with sildenafil compared with a placebo had no effect on the exercise capacity or clinical status of patients with heart failure with preserved ejection fraction (HFpEF) in the PhosphodiesteRasE-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure with Preserved Ejection Fraction (RELAX) clinical trial. Metabolic impairments may explain the neutral results. Objective: To test the hypothesis that profiling metabolites in the RELAX trial would clarify the mechanisms of sildenafil effects and identify metabolites associated with clinical outcomes in HFpEF...
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492909/the-controversial-epidemiology-of-left-ventricular-dysfunction-in-patients-with-myotonic-dystrophy-type-1
#11
Vincenzo Russo, Andrea Antonio Papa, Gerardo Nigro
No abstract text is available yet for this article.
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492868/efficacy-of-flecainide-in-the-treatment-of-catecholaminergic-polymorphic-ventricular-tachycardia-a-randomized-clinical-trial
#12
Prince J Kannankeril, Jeremy P Moore, Marina Cerrone, Silvia G Priori, Naomi J Kertesz, Pamela S Ro, Anjan S Batra, Elizabeth S Kaufman, David L Fairbrother, Elizabeth V Saarel, Susan P Etheridge, Ronald J Kanter, Michael P Carboni, Matthew V Dzurik, Darlene Fountain, Heidi Chen, E Wesley Ely, Dan M Roden, Bjorn C Knollmann
Importance: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal genetic arrhythmia syndrome characterized by polymorphic ventricular tachycardia with physical or emotional stress, for which current therapy with β-blockers is incompletely effective. Flecainide acetate directly suppresses sarcoplasmic reticulum calcium release-the cellular mechanism responsible for triggering ventricular arrhythmias in CPVT-but has never been assessed prospectively. Objective: To determine whether flecainide dosed to therapeutic levels and added to β-blocker therapy is superior to β-blocker therapy alone for the prevention of exercise-induced arrhythmias in CPVT...
May 10, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28492917/coverage-of-magnetic-resonance-imaging-for-patients-with-cardiac-devices-improving-the-coverage-with-evidence-development-program
#13
Daniel B Kramer, Aaron S Kesselheim
No abstract text is available yet for this article.
May 8, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467549/balancing-the-training-of-future-cardiologists-with-the-provision-of-team-based-care
#14
Susan M Fernandes, Rhonda L Larsen, Garrett K Chan
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467542/a-67-year-old-man-with-irregular-pulse
#15
Ashish Rai, Howard M Waldman, Nureddin K Almaddah
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467539/cardiovascular-risk-prediction-in-patients-with-human-immunodeficiency-virus
#16
Paolo Raggi, Davide De Francesco, Giovanni Guaraldi
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467533/shared-goals-and-clear-roles-for-cardiovascular-team-based-care
#17
John E Brush
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467529/collaborative-care-in-an-evolving-health-care-delivery-landscape-cardiology-fellows-in-training-and-advanced-practice-professionals
#18
Muthiah Vaduganathan, Nilay K Patel, Brian A Bergmark
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467528/cardiovascular-risk-prediction-in-patients-with-human-immunodeficiency-virus-reply
#19
Matthew J Feinstein, Joseph A Delaney, Heidi M Crane
No abstract text is available yet for this article.
May 3, 2017: JAMA Cardiology
https://www.readbyqxmd.com/read/28467527/association-of-transcatheter-aortic-valve-replacement-with-30-day-renal-function-and-1-year-outcomes-among-patients-presenting-with-compromised-baseline-renal-function-experience-from-the-partner-1-trial-and-registry
#20
Nirat Beohar, Darshan Doshi, Vinod Thourani, Hanna Jensen, Susheel Kodali, Feifan Zhang, Yiran Zhang, Charles Davidson, Patrick McCarthy, Michael Mack, Samir Kapadia, Martin Leon, Ajay Kirtane
Importance: The frequency of baseline renal impairment among high-risk and inoperable patients with severe aortic stenosis undergoing a transcatheter aortic valve replacement (TAVR) and the effect of TAVR on subsequent renal function are, to our knowledge, unknown. Objective: To determine the effect of TAVR among patients with baseline renal impairment. Design, Setting, and Participants: This substudy of patients with baseline renal impairment (estimated glomerular filtration rate [eGFR] ≤ 60 mL/min) and paired baseline and 30-day measures of renal function undergoing TAVR in the PARTNER 1 trial and continued access registries was conducted in 25 centers in the United States and Canada...
May 3, 2017: JAMA Cardiology
journal
journal
53384
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"